FY2024 EPS Estimates for Viking Therapeutics, Inc. Lowered by Analyst (NASDAQ:VKTX)

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) – Research analysts at SVB Leerink lowered their FY2024 EPS estimates for shares of Viking Therapeutics in a report released on Tuesday, May 16th. SVB Leerink analyst T. Smith now forecasts that the biotechnology company will post earnings per share of ($1.16) for the year, down from their […]

Related Keywords

San Diego ,California ,United States ,Michaela Dinerman ,Stifel Nicolaus ,Roth Mkm ,Marianna Mancini ,Maxim Group ,Virtu Financial ,Securities Exchange Commission ,Cetera Advisor Networks ,Therapeutics Inc ,Nasdaq ,Envestnet Asset Management Inc ,Therapeutics Company Profile ,Viking Therapeutics ,Get Rating ,Viking Therapeutic ,Truist Financial ,Therapeutics Trading Down ,Exchange Commission ,Advisor Networks ,Gate Manager ,Envestnet Asset Management ,Brian Lian ,Viking Therapeutics Daily ,Nasdaq Vktx ,Vktx ,Medical ,Earnings Estimates ,Svb Leerink Llc ,